Daniel A. Balikov

1.5k citations
37 papers · 793 indexed · h-index 15

Daniel A. Balikov

35 papers receiving 780 citations

Peers

Daniel A. Balikov
Comparison fields: 5 of 78
  • Biomaterials 221
  • Biomedical Engineering 485
  • Molecular Medicine 25
  • Genetics 43
  • Cellular and Molecular Neuroscience 70
Replace Jinjie Cui with:
Jinjie Cui China
Ho Pan Bei Hong Kong
Pilnam Kim South Korea
Alessandra Marrella Italy
Shreyas Kuddannaya Singapore
Eunkyung Ko United States
Varadraj N. Vernekar United States
Jung-Youn Shin South Korea
Xingzhi Liu China
Daniel A. Balikov relative to Jinjie Cui China Jinjie Cui's profile →
Citations per field
00.5×20×40×60×80×91×
Jinjie Cui · 1×
Citations per year

Countries citing papers authored by Daniel A. Balikov

Since Specialization
Citations

This map shows the geographic impact of Daniel A. Balikov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Balikov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Balikov more than expected).

Fields of papers citing papers by Daniel A. Balikov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Balikov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Balikov. The network helps show where Daniel A. Balikov may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniel A. Balikov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel A. Balikov Line = papers co-authored together Daniel A. Balikov links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20231
3 20220
4 20218
5 20213
6 20214
7 20212
8 202014
9 201917
10 201913
11 20189
12 201720
13 201642
14 20169
15 201646
16 201680
17 201535
18 201567
19 201516
20 201442

About Daniel A. Balikov

Daniel A. Balikov is a scholar working on Biomaterials, Genetics and Biomedical Engineering, having authored 37 papers that have together received 793 indexed citations. Recurring topics across this work include 3D Printing in Biomedical Research (9 papers), Electrospun Nanofibers in Biomedical Applications (7 papers), Tissue Engineering and Regenerative Medicine (5 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Pluripotent Stem Cells Research (4 papers), Bone Tissue Engineering Materials (4 papers), Mesenchymal stem cell research (4 papers) and Graphene and Nanomaterials Applications (3 papers). The work is most often cited by research in Biomaterials (221 citations), Biomedical Engineering (485 citations) and Molecular Medicine (25 citations). Daniel A. Balikov has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Hak‐Joon Sung, Spencer W. Crowder, Dhiraj Prasai, Leon M. Bellan, Rutwik Rath, Hojae Bae, Kirill I. Bolotin, Jung Bok Lee, Ethan S. Lippmann and Shannon L. Faley. Their work appears in journals such as Biomaterials, ACS Applied Materials & Interfaces and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026